Clinical Research Platform On Urologic Cancer Treatment And Outcome (Registry Platform Urologic Cancer; CARAT)
Condition: Renal Cell Carcinoma, Urothelial Carcinoma
Study Type: Observational [Patient Registry]
Clinical Trials Identifier NCT 8-digits: NCT03374267
Sponsor: iOMEDICO AG
Phase:
Eligibility:
- Age: minimum 18 Years maximum N/A
- Gender: All
Inclusion Criteria:
- Female and male patients with aRCC or aUBC (locally advanced, inoperable or metastatic)
- Patients at start of their first-line systemic treatment for aRCC or aUBC
- Written informed consent
- Patients participating in the PRO module: signing of in-formed consent form and completion of baseline questionnaire before start of initial systemic treatment
- Patients not participating in the PRO module: within twelve weeks after start of systemic first-line for aRCC or aUBC
- Age ≥ 18 years
Exclusion Criteria:
- Patients with prior systemic therapy for aRCC or aUBC
- No systemic treatment for aRCC or aUBC
View trial on ClinicalTrials.gov
{{footer-clinical-trials-navigation}}